肾血管性高血压的介入治疗

Interventional therapy for renal vascular hypertension

目的 研究经皮腔内血管成形术加内支架植入术治疗肾动脉狭窄所致肾血管性高血压的临床效果。 方法 选用Palmaz支架 ,对 7例大动脉炎、2例动脉粥样硬化、3例纤维肌性发育不良所致肾动脉病变先行经皮腔内血管成形术 ,然后放置支架 ,术后患者均行常规抗凝治疗。 结果 12例患者经皮腔内血管成形术加支架植入术技术成功率为 10 0 % ,血压下降 6 0～ 12 0 / 35～ 10 0mmHg近期随访 3～ 32个月未见复发。 结论 经皮腔内血管成形术加支架植入术治疗肾血管性高血压效果满意 ,创伤小 ,患者痛苦少 。

Objective To study the clinical efficacy of percutaneous transluminal renal angioplasty and intraluminal stent implantation for pationts with renal vascular hypertension. [WT5”HZ]Methods[WT5”BZ] Percutaneous transluminal renal angioplasty was performed first, and palmaz stent was implanted in to the renal artery that was affected by aortoarteritis (7 patients), atheroscleroticlesion (2) or fibromuscular dysplasia (3). Anticoagulants were given after implantation of intraluminal stent. Results The success rate of percutaneous transluminal renal angioplasty and stent placement was 100%. Follow up for 3 32 months showed no recurrence, BP was normal. Conclusion Percutaneous transluminal renal angioplasty with stent placement is a good method for treating renal vascular hypertension because of its minimal invasivenness and less pain.